Cassava Sciences Inc (SAVA)
26.14
+0.96
(+3.81%)
USD |
NASDAQ |
Nov 14, 16:00
26.00
-0.14
(-0.54%)
Pre-Market: 09:18
Cassava Sciences Cash and Short Term Investments (Quarterly): 148.98M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 148.98M |
| June 30, 2024 | 207.29M |
| March 31, 2024 | 124.17M |
| December 31, 2023 | 121.14M |
| September 30, 2023 | 142.35M |
| June 30, 2023 | 168.44M |
| March 31, 2023 | 187.47M |
| December 31, 2022 | 201.02M |
| September 30, 2022 | 174.66M |
| June 30, 2022 | 197.23M |
| March 31, 2022 | 209.69M |
| December 31, 2021 | 233.44M |
| September 30, 2021 | 241.52M |
| June 30, 2021 | 278.25M |
| March 31, 2021 | 282.19M |
| December 31, 2020 | 93.51M |
| September 30, 2020 | 24.07M |
| June 30, 2020 | 25.25M |
| March 31, 2020 | 25.60M |
| December 31, 2019 | 23.08M |
| September 30, 2019 | 17.80M |
| June 30, 2019 | 18.53M |
| March 31, 2019 | 19.12M |
| December 31, 2018 | 19.81M |
| September 30, 2018 | 20.44M |
| Date | Value |
|---|---|
| June 30, 2018 | 9.608M |
| March 31, 2018 | 10.73M |
| December 31, 2017 | 10.48M |
| September 30, 2017 | 11.92M |
| June 30, 2017 | 14.07M |
| March 31, 2017 | 17.26M |
| December 31, 2016 | 18.71M |
| September 30, 2016 | 21.76M |
| June 30, 2016 | 24.63M |
| March 31, 2016 | 28.11M |
| December 31, 2015 | 31.30M |
| September 30, 2015 | 34.89M |
| June 30, 2015 | 37.30M |
| March 31, 2015 | 39.25M |
| December 31, 2014 | 40.59M |
| September 30, 2014 | 43.15M |
| June 30, 2014 | 44.82M |
| March 31, 2014 | 47.10M |
| December 31, 2013 | 49.84M |
| September 30, 2013 | 51.03M |
| June 30, 2013 | 52.84M |
| March 31, 2013 | 54.39M |
| December 31, 2012 | 56.25M |
| September 30, 2012 | 92.53M |
| June 30, 2012 | 93.94M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
23.08M
Minimum
Dec 2019
282.19M
Maximum
Mar 2021
155.47M
Average
171.55M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 8.094B |
| Seelos Therapeutics Inc | 0.294M |
| EyePoint Pharmaceuticals Inc | 253.79M |
| PTC Therapeutics Inc | 1.013B |
| Adverum Biotechnologies Inc | 153.24M |